Search

Your search keyword '"Immovilli, P."' showing total 36 results

Search Constraints

Start Over You searched for: Author "Immovilli, P." Remove constraint Author: "Immovilli, P." Database OpenAIRE Remove constraint Database: OpenAIRE
36 results on '"Immovilli, P."'

Search Results

1. Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register

2. Signs and symptoms of COVID-19 in patients with multiple sclerosis

3. Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies

4. DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France: a pooled analysis from Italy and France

5. Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis

6. Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy

7. Correction to: Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study (Journal of Neuro-Oncology, (2016), 128, 1, (157-162), 10.1007/s11060-016-2093-1)

8. Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study

9. Erratum to: Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy

10. Erratum to: Survival prediction in high-grade gliomas using CT perfusion imaging [J Neurooncol (2015) 123, 93-102, DOI 10.1007/s11060-015-1766-5]

11. Experience of an information aid for newly diagnosed multiple sclerosis patients: A qualitative study on the SIMS-Trial

12. Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis

13. The Multiple Sclerosis Knowledge Questionnaire: a self-administered instrument for recently diagnosed patients

14. Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis

15. Experience of an information aid for newly diagnosed multiple sclerosis patients: a qualitative study on the SIMS-Trial

17. Implementation of the 'Sapere Migliora' information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial

18. Implementation of the 'Sapere Migliora' information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial

19. Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III

20. Erratum to: Survival prediction in high-grade gliomas using CT perfusion imaging

21. Definition of miRNAs Expression Profile in Glioblastoma Samples: The Relevance of Non-Neoplastic Brain Reference

22. Updating on Italian stroke units: the 'CCM study'

24. Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis

25. Interferon Beta therapy and pregnancy outcomes in patients with multiple sclerosis

27. Post-stroke rehabilitation in Italy: inconsistencies across regional strategies

29. The effect of air pollution on COVID‐19 severity in a sample of patients with multiple sclerosis

30. Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

31. Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy

32. Dimethyl fumarate-induced lymphocyte count drop is related to clinical effectiveness in relapsing-remitting multiple sclerosis

33. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study

34. COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context

35. Dynamic pattern of clinical and MRI findings in a tumefactive demyelinating lesion: a case report

36. Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?

Catalog

Books, media, physical & digital resources